TRIM56 and triple-negative breast carcinoma: TRIM56 depletion decreased cell proliferation in both MCF-7 and T47D cells (Fig. 2A and Supplementary Fig. 1B), but had no effect on the triple-negative breast cancer cell line (Supplementary Fig. 1C).